145 related articles for article (PubMed ID: 28012560)
1. Non-traditional roles of complement in type 2 diabetes: Metabolism, insulin secretion and homeostasis.
King BC; Blom AM
Mol Immunol; 2017 Apr; 84():34-42. PubMed ID: 28012560
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes.
Westwell-Roper C; Nackiewicz D; Dan M; Ehses JA
Immunol Cell Biol; 2014 Apr; 92(4):314-23. PubMed ID: 24492799
[TBL] [Abstract][Full Text] [Related]
3. Whole-Genome Bisulfite Sequencing of Human Pancreatic Islets Reveals Novel Differentially Methylated Regions in Type 2 Diabetes Pathogenesis.
Volkov P; Bacos K; Ofori JK; Esguerra JL; Eliasson L; Rönn T; Ling C
Diabetes; 2017 Apr; 66(4):1074-1085. PubMed ID: 28052964
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
5. Anti-pancreatic immunity. In vitro studies of cellular and humoral immune reactions directed toward pancreatic islets.
Boitard C; Saï P; Debray-Sachs M; Assan R; Hamburger J
Clin Exp Immunol; 1984 Mar; 55(3):571-80. PubMed ID: 6368060
[TBL] [Abstract][Full Text] [Related]
6. Block in insulin release from column-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement.
Kanatsuna T; Lernmark A; Rubenstein AH; Steiner DF
Diabetes; 1981 Mar; 30(3):231-4. PubMed ID: 7009272
[TBL] [Abstract][Full Text] [Related]
7. Munc18b Increases Insulin Granule Fusion, Restoring Deficient Insulin Secretion in Type-2 Diabetes Human and Goto-Kakizaki Rat Islets with Improvement in Glucose Homeostasis.
Qin T; Liang T; Zhu D; Kang Y; Xie L; Dolai S; Sugita S; Takahashi N; Ostenson CG; Banks K; Gaisano HY
EBioMedicine; 2017 Feb; 16():262-274. PubMed ID: 28163042
[TBL] [Abstract][Full Text] [Related]
8. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
9. Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes.
Cuenco J; Dalmas E
Handb Exp Pharmacol; 2022; 274():227-251. PubMed ID: 35044537
[TBL] [Abstract][Full Text] [Related]
10. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.
Hasnain SZ; Borg DJ; Harcourt BE; Tong H; Sheng YH; Ng CP; Das I; Wang R; Chen AC; Loudovaris T; Kay TW; Thomas HE; Whitehead JP; Forbes JM; Prins JB; McGuckin MA
Nat Med; 2014 Dec; 20(12):1417-26. PubMed ID: 25362253
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor-deficient islet β-cells exhibit alteration in genetic markers of insulin secretion and inflammation. A transcriptome analysis in the male mouse.
Xu W; Niu T; Xu B; Navarro G; Schipma MJ; Mauvais-Jarvis F
J Diabetes Complications; 2017 May; 31(5):787-795. PubMed ID: 28343791
[TBL] [Abstract][Full Text] [Related]
12. The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation.
Kulak K; Westermark GT; Papac-Milicevic N; Renström E; Blom AM; King BC
Diabetologia; 2017 Aug; 60(8):1522-1533. PubMed ID: 28500395
[TBL] [Abstract][Full Text] [Related]
13. Macrophages and islet inflammation in type 2 diabetes.
Eguchi K; Manabe I
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():152-8. PubMed ID: 24003932
[TBL] [Abstract][Full Text] [Related]
14. Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes.
Bennet H; Balhuizen A; Medina A; Dekker Nitert M; Ottosson Laakso E; Essén S; Spégel P; Storm P; Krus U; Wierup N; Fex M
Peptides; 2015 Sep; 71():113-20. PubMed ID: 26206285
[TBL] [Abstract][Full Text] [Related]
15. Does epigenetic dysregulation of pancreatic islets contribute to impaired insulin secretion and type 2 diabetes?
Dayeh T; Ling C
Biochem Cell Biol; 2015 Oct; 93(5):511-21. PubMed ID: 26369706
[TBL] [Abstract][Full Text] [Related]
16. Effects of islet cell surface antibodies and complement on the release of insulin and chromium from perifused beta cells.
Kanatsuna T; Freedman ZR; Rubenstein AH; Lernmark A
Clin Exp Immunol; 1982 Jan; 47(1):85-92. PubMed ID: 7047026
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type 1 diabetes.
Sensi M; Zuccarini O; Spencer KM; Beales P; Pujol-Borrell R; Pozzilli P
Diabetes Res; 1985 Jan; 2(1):1-4. PubMed ID: 3888494
[TBL] [Abstract][Full Text] [Related]
18. [Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes].
Cerasi E; Ktorza A
Med Sci (Paris); 2007 Oct; 23(10):885-94. PubMed ID: 17937902
[TBL] [Abstract][Full Text] [Related]
19. Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects.
Riva M; Nitert MD; Voss U; Sathanoori R; Lindqvist A; Ling C; Wierup N
Cell Tissue Res; 2011 Dec; 346(3):393-405. PubMed ID: 22108805
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion.
Sebastiani G; Po A; Miele E; Ventriglia G; Ceccarelli E; Bugliani M; Marselli L; Marchetti P; Gulino A; Ferretti E; Dotta F
Acta Diabetol; 2015 Jun; 52(3):523-30. PubMed ID: 25408296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
